Yardley Dermatology Associates, Pc

CLIA Laboratory Citation Details

3
Total Citations
9
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 39D0887030
Address 803 Floral Vale Boulevard, Yardley, PA, 190675513
City Yardley
State PA
Zip Code190675513
Phone(215) 579-6155

Citation History (3 surveys)

Survey - April 29, 2025

Survey Type: Standard

Survey Event ID: T1TW11

Deficiency Tags: D5413

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) (b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (b)(1) Water quality. (b)(2) Temperature. (b)(3) Humidity. (b)(4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on review of the laboratory's temperature records, and interview with the Histology Technician (HT), the laboratory failed to monitor and document temperatures to ensure operating conditions were met for reliable test system operation and test result reporting for 2 of 2 cryostats (Avantik QS11 and QS12) used to perform MOHS microscopic slide examinations from 06/07/2023 to date of survey. Findings Include: 1. On the day of the survey, 04/29/2025 at 09:15 am, review of the laboratory's temperature logs revealed the laboratory failed to monitor and document 2 of 2 cryostat temperatures (manufacturers acceptable range: -21 to -26 degrees Celsius) to ensure reliable test system operation and test result reporting for 06/07 /2023 to 04/29/2025 when MOHS microscopic slide examinations were performed. 2. The laboratory performed 9982 histopathology examinations in 2024 (CMS 116, estimated annual volume). 3. The HT confirmed the findings above on 04/2/2025 at 09:25 am. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 7, 2023

Survey Type: Standard

Survey Event ID: EMST11

Deficiency Tags: D5221 D6125

Summary:

Summary Statement of Deficiencies D5221 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(d) All proficiency testing evaluation and verification activities must be documented. This STANDARD is not met as evidenced by: Based on a review of Histopathology peer review records and interview with Testing Personnel (TP) # 4 (CMS 209), the laboratory failed to provide documentation of the verification activities of the Histopathology Slide examined by 2 of 2 TP in 2021 and 2022. Findings include: 1. On the day of survey, 06/07/2023 at 12:00 PM, a Review of the Histopathology Slide peer review records revealed that the laboratory failed to provide documentation of verification activities for the Histopathology Slide peer review in 2021 and 2022 for TP #1 and #2. 2. Laboratory failed to provide a procedure manual for peer review of histopathology slides examination. 3. Interview with TP #4 at 12:40 PM confirmed that the verification activities were not documented in detail. D6125 TECHNICAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1451(b)(8)(v) The procedures for evaluation of the competency of the staff must include, but are not limited to assessment of test performance through testing previously analyzed specimens, internal blind testing samples or external proficiency testing samples. This STANDARD is not met as evidenced by: Based on review of Competency Assessment records and interview with Testing Personnel (TP) #4 (CMS 209) Technical Supervisor (TS) failed to provide documentation of the assessment of test performance in the competency evaluation of 4 of 5 testing personnel who performed gross examinations, mapping and specimen Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- inking of frozen sections of histopathology from 2021 through the date of survey. Findings include: 1. On the day of the survey 06/07/2023 at 11:50 AM, a review of competency assessments for Gross examinations and specimen inking of frozen sections revealed that the TS did not include assessment of test performance through previously analyzed specimens, internal blind testing samples, or external proficiency testing samples from 2021 to 2023. 2. The procedure manual provided by the laboratory for Proficiency Testing (PT) did not include a direction for competency assessment of gross examinations, mapping, and specimen inking for frozen sections of histopathology. 3. The laboratory reported an annual test volume of 8561 for Histopathology (CMS-116). 4. TP #4 confirmed the above findings on 06/07/2023 around 12:45 PM. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 4, 2021

Survey Type: Standard

Survey Event ID: MJO811

Deficiency Tags: D5449 D6168 D6171 D5449 D6168 D6171

Summary:

Summary Statement of Deficiencies D5449 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(ii)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each qualitative procedure, include a negative and positive control material; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on review of quality control records and interview with testing personnel #12 (TP12), the laboratory failed to include a positive and a negative control materials each day of performing Potassium Hydroxide (KOH) microscopic examination on patient specimens for 2020 Findings include: 1. On the date of survey, 05/04/2021, the laboratory could not provide the documentation of quality control performed on the KOH microscopic examinations for 2020. 2. Two specimens were examined for KOH test in 2020. 3. The TP12 confirmed the findings above on 05/04/2021 at 10:50 a.m. D6168 TESTING PERSONNEL CFR(s): 493.1487 The laboratory has a sufficient number of individuals who meet the qualification requirements of 493.1489 of this subpart to perform the functions specified in 493. 1495 of this subpart for the volume and complexity of testing performed. This CONDITION is not met as evidenced by: Based on review of the CLIA's Laboratory Personnel Report (Form CMS-209), review of personnel qualification records, and interview with the Testing Personnel Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- (TP)#12, the laboratory failed to ensure that each individual performing High Complexity testing (2 of 13 TP) is qualified. Refer to D6171 D6171 TESTING PERSONNEL QUALIFICATIONS CFR(s): 493.1489(b) (b) Meet one of the following requirements: (b)(1) Be a doctor of medicine, doctor of osteopathy, or doctor of podiatric medicine licensed to practice medicine, osteopathy, or podiatry in the State in which the laboratory is located or have earned a doctoral, master's or bachelor's degree in a chemical, physical, biological or clinical laboratory science, or medical technology from an accredited institution; (b)(2)(i) Have earned an associate degree in a laboratory science, or medical laboratory technology from an accredited institution or-- (b)(2)(ii) Have education and training equivalent to that specified in paragraph (b)(2)(i) of this section that includes-- (b)(2)(ii)(A) At least 60 semester hours, or equivalent, from an accredited institution that, at a minimum, include either-- (b)(2)(ii)(A)(1) 24 semester hours of medical laboratory technology courses; or (b)(2)(ii)(A)(2) 24 semester hours of science courses that include-- (b)(2) (ii)(A)(2)(i) Six semester hours of chemistry; (b)(2)(ii)(A)(2)(ii) Six semester hours of biology; and (b)(2)(ii)(A)(2)(iii) Twelve semester hours of chemistry, biology, or medical laboratory technology in any combination; and (b)(2)(ii)(B) Have laboratory training that includes either of the following: (b)(2)(ii)(B)(1) Completion of a clinical laboratory training program approved or accredited by the ABHES, the CAHEA, or other organization approved by HHS. (This training may be included in the 60 semester hours listed in paragraph (b)(2)(ii)(A) of this section.) (b)(2)(ii)(B)(2) At least 3 months documented laboratory training in each specialty in which the individual performs high complexity testing. (b)(3) Have previously qualified or could have qualified as a technologist under 493.1491 on or before February 28, 1992; (b) (4) On or before April 24, 1995 be a high school graduate or equivalent and have either-- (b)(4)(i) Graduated from a medical laboratory or clinical laboratory training program approved or accredited by ABHES, CAHEA, or other organization approved by HHS; or (b)(4)(ii) Successfully completed an official U.S. military medical laboratory procedures training course of at least 50 weeks duration and have held the military enlisted occupational specialty of Medical Laboratory Specialist (Laboratory Technician); (b)(5)(i) Until September 1, 1997-- (b)(5)(i)(A) Have earned a high school diploma or equivalent; and (b)(5)(i)(B) Have documentation of training appropriate for the testing performed before analyzing patient specimens. Such training must ensure that the individual has-- (b)(5)(i)(B)(1) The skills required for proper specimen collection, including patient preparation, if applicable, labeling, handling, preservation or fixation, processing or preparation, transportation and storage of specimens; (b)(5)(i)(B)(2) The skills required for implementing all standard laboratory procedures; (b)(5)(i)(B)(3) The skills required for performing each test method and for proper instrument use; (b)(5)(i)(B)(4) The skills required for performing preventive maintenance, troubleshooting, and calibration procedures related to each test performed; (b)(5)(i)(B)(5) A working knowledge of reagent stability and storage; (b)(5)(i)(B)(6) The skills required to implement the quality control policies and procedures of the laboratory; (b)(5)(i)(B)(7) An awareness of the factors that influence test results; and (b)(5)(i)(B)(8) The skills required to assess and verify the validity of patient test results through the evaluation of quality control values before reporting patient test results; and (b)(5)(i)(B)(8)(ii) As of September 1, 1997, be qualified under 493.1489(b)(1), (b)(2), or (b)(4), except for those individuals qualified under paragraph (b)(5)(i) of this section who were performing high complexity testing on or before April 24, 1995; (b)(6) For blood gas analysis-- (b)(6) (i) Be qualified under 493.1489(b)(1), (b)(2), (b)(3), (b)(4), or (b)(5); (b)(6)(ii) Have -- 2 of 3 -- earned a bachelor's degree in respiratory therapy or cardiovascular technology from an accredited institution; or (b)(6)(iii) Have earned an associate degree related to pulmonary function from an accredited institution; or (b)(7) For histopathology, meet the qualifications of 493.1449 (b) or (l) to perform tissue examinations. This STANDARD is not met as evidenced by: Based on review of the CLIA's Laboratory Personnel Report (Form CMS-209), review of personnel qualification records, and interview with the Testing Personnel (TP)#12, the laboratory failed to ensure that each individual performing High Complexity testing (2 of 13 TP) had the minimum qualifications required from May, 2019 to the day of survey. Findings Include: 1. On the date of survey 05/04/2021 at 09: 15 am, the surveyor reviewed the credentials of the testing personnel listed on the CMS 209 (TP12 and TP13) and discovered that 2 of 2 testing personnel who performed grossing for Mohs micrographic examinations from May, 2019 through the day of survey, did not have the minimum qualifications. 2. The TP12 confirmed the finding above on 05/04/2021 at 11:25 a.m. . -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access